Terms: = Liver cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Diagnosis
33 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. A TGF-β-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
Xiang X; Hao Y; Cheng C; Hu H; Chen H; Tan J; Wang Y; Liu X; Peng B; Liao J; Wang J; Xie Y; Liu J; Chen S; Xu L; Xie W; Xue R; Kuang M; Xu Z; Jiang H; Peng S
Hepatology; 2024 Mar; 79(3):650-665. PubMed ID: 37459556
[TBL] [Abstract] [Full Text] [Related]
3. Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS.
Yoshimoto Suzuki Y; Yamanaka J; Miyazaki O; Nozawa K; Ohira M; Kamijo T; Shichino H
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e779-e781. PubMed ID: 35001057
[TBL] [Abstract] [Full Text] [Related]
4. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
[TBL] [Abstract] [Full Text] [Related]
5. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
Tas ML; Nagtegaal M; Kraal KCJM; Tytgat GAM; Abeling NGGM; Koster J; Pluijm SMF; Zwaan CM; de Keizer B; Molenaar JJ; van Noesel MM
Pediatr Blood Cancer; 2020 Apr; 67(4):e28061. PubMed ID: 31736229
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
7. Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
Morgenstern DA; Pötschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
Pediatr Blood Cancer; 2018 Nov; 65(11):e27363. PubMed ID: 30015396
[TBL] [Abstract] [Full Text] [Related]
8. Recent Progress of Wnt Pathway Inhibitor Dickkopf-1 in liver cancer.
Li J; Gong W; Li X; Wan R; Mo F; Zhang Z; Huang P; Hu Z; Lai Z; Lu X; Zhao Y
J Nanosci Nanotechnol; 2018 Aug; 18(8):5192-5206. PubMed ID: 29458569
[TBL] [Abstract] [Full Text] [Related]
9. Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.
Coulter DW; Boettner AD; Kortylewicz ZP; Enke SP; Luther JA; Verma V; Baranowska-Kortylewicz J
J Pediatr Hematol Oncol; 2017 May; 39(4):272-281. PubMed ID: 28375942
[TBL] [Abstract] [Full Text] [Related]
10. A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.
Singh V; Manalang M; Singh M; Apte U
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):654-657. PubMed ID: 28187036
[TBL] [Abstract] [Full Text] [Related]
11. Solid tumors of childhood display specific serum microRNA profiles.
Murray MJ; Raby KL; Saini HK; Bailey S; Wool SV; Tunnacliffe JM; Enright AJ; Nicholson JC; Coleman N
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):350-60. PubMed ID: 25416717
[TBL] [Abstract] [Full Text] [Related]
12. High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
Fendler WP; Melzer HI; Walz C; von Schweinitz D; Coppenrath E; Schmid I; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1701-10. PubMed ID: 23857458
[TBL] [Abstract] [Full Text] [Related]
13. Successful liver transplantation in an infant with stage 4S(M) neuroblastoma.
Steele M; Jones NL; Ng V; Kamath B; Avitzur Y; Chami R; Cutz E; Fecteau A; Baruchel S
Pediatr Blood Cancer; 2013 Mar; 60(3):515-7. PubMed ID: 23152322
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.
Machado I; Noguera R; Santonja N; Donat J; Fernandez-Delgado R; Acevedo A; Baragaño M; Navarro S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):150-8. PubMed ID: 19770707
[TBL] [Abstract] [Full Text] [Related]
15. [4S neuroblastoma with bilateral adrenal tumors].
Kerdudo C; Corradini N; Michon J; Leverger G
Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
[TBL] [Abstract] [Full Text] [Related]
16. Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP).
Schleiermacher G; Rubie H; Hartmann O; Bergeron C; Chastagner P; Mechinaud F; Michon J;
Br J Cancer; 2003 Aug; 89(3):470-6. PubMed ID: 12888814
[TBL] [Abstract] [Full Text] [Related]
17. Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's cancer Group and the Pediatric Oncology Group.
Hamrick SE; Olshan AF; Neglia JP; Pollock BH
Paediatr Perinat Epidemiol; 2001 Oct; 15(4):328-37. PubMed ID: 11703680
[TBL] [Abstract] [Full Text] [Related]
18. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract] [Full Text] [Related]
19. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract] [Full Text] [Related]
20. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
DuBois SG; Kalika Y; Lukens JN; Brodeur GM; Seeger RC; Atkinson JB; Haase GM; Black CT; Perez C; Shimada H; Gerbing R; Stram DO; Matthay KK
J Pediatr Hematol Oncol; 1999; 21(3):181-9. PubMed ID: 10363850
[TBL] [Abstract] [Full Text] [Related]
[Next]
